medullay thyroid cancer

LIBRETTO-531 Trial: Selpercatinib in Medullay Thyroid Cancer

Objective: To determine if the study drug selpercatinib is safer and more effective compared to standard treatment in participants with RET-mutant medullary thyroid cancer (MTC) that cannot be removed by surgery or has spread to other parts of the body. … Read More